{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:31:19Z","timestamp":1789950679088,"version":"4.0.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Recovery and Resilience Plan, Investment PE8 \u2013 Project Age-It: \u201cAgeing Well in an Ageing Society","award":["AGE-IT \u2013CUP B83C22004800006"],"award-info":[{"award-number":["AGE-IT \u2013CUP B83C22004800006"]}]},{"name":"Recovery and Resilience Plan, Investment PE8 \u2013 Project Age-It: \u201cAgeing Well in an Ageing Society","award":["AGE-IT \u2013CUP B83C22004800006"],"award-info":[{"award-number":["AGE-IT \u2013CUP B83C22004800006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Although anti-hypertensive medications, including thiazides and \u03b2-blockers (BBs) in particular, have been suggested to cause erectile dysfunction (ED) their real contribution is still conflicting. The aim of this paper is to summarize available evidence providing an evidence-based critical analysis of the topic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An overall comprehensive narrative review was performed using Medline, Embase and Cochrane search. In addition, to better understand the impact of BBs on ED a specific systematic review was also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The negative role of centrally acting drugs, such as clonidine and \u03b1-methyldopa, is well documented althuogh limited controlled trials are available. Angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs), and calcium-channel-blockers (CCBs) have neutral (CCBs) or even positive (ACEis and ARBs) effects on erectile function. Despite some preliminary negative reports, more recent evidence does not confirm the negative impact of thiazides. BBs should be still considered the class of medications more often associated with ED, although better outcomes can be drawn with nebivolol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sexual function should be assessed in all patients with arterial hypertension, either at diagnosis or after the prescription of specific medications. A close related patient-physician interaction and discussion can overcome possible negative outcomes allowing a successful management of possible side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-024-04020-x","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:02:45Z","timestamp":1726196565000},"page":"11-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Anti-hypertensive medications and erectile dysfunction: focus on \u03b2-blockers"],"prefix":"10.1007","volume":"87","author":[{"given":"G.","family":"Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pizzocaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Salvio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sparano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"Jan 10064","key":"4020_CR1","first-page":"37","volume":"389","author":"NCD Risk Factor Collaboration (NCD-RisC","year":"2017","unstructured":"NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet 389(Jan 10064), 37\u201355 (2017)","journal-title":"Lancet"},{"issue":"Dec 6","key":"4020_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/08037051.2018.1527177","volume":"27","author":"B Williams","year":"2018","unstructured":"B. Williams, G. Mancia, W. Spiering et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press 27(Dec 6), 314\u2013340 (2018)","journal-title":"Blood Press"},{"issue":"Jan 1","key":"4020_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1743-6109.2010.01966.x","volume":"8","author":"G Corona","year":"2011","unstructured":"G. Corona, M. Monami, V. Boddi et al. Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. J Sex Med 8(Jan 1), 247\u2013254 (2011)","journal-title":"J Sex Med"},{"issue":"Jan 1","key":"4020_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamainternmed.2017.6015","volume":"178","author":"M Brunstr\u00f6m","year":"2018","unstructured":"M. Brunstr\u00f6m, B. Carlberg, Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med 178(Jan 1), 28\u201336 (2018)","journal-title":"JAMA Intern Med"},{"issue":"Oct 5","key":"4020_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10557-021-07197-9","volume":"36","author":"IT Farmakis","year":"2022","unstructured":"I.T. Farmakis, N. Pyrgidis, I. Doundoulakis et al. Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(Oct 5), 903\u2013914 (2022)","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Jun 6","key":"4020_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s40618-023-02015-5","volume":"46","author":"G Corona","year":"2023","unstructured":"G. Corona, D. Cucinotta, G. Di Lorenzo et al. The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction. J Endocrinol Invest 46(Jun 6), 1241\u20131274 (2023)","journal-title":"J Endocrinol Invest"},{"issue":"Jan 1 Pt 1","key":"4020_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","volume":"29","author":"RH Grimm Jr","year":"1997","unstructured":"R.H. Grimm Jr, G.A. Grandits, R.J. Prineas et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 29(Jan 1 Pt 1), 8\u201314 (1997)","journal-title":"Hypertension"},{"issue":"Feb 2","key":"4020_CR8","first-page":"460","volume":"163","author":"CB Johannes","year":"2000","unstructured":"C.B. Johannes, A.B. Araujo, H.A. Feldman et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 163(Feb 2), 460\u2013463 (2000)","journal-title":"J Urol"},{"issue":"Apr 4 Pt 1","key":"4020_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1743-6109.2009.01601.x","volume":"7","author":"G Corona","year":"2010","unstructured":"G. Corona, D.M. Lee, G. Forti et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med 7(Apr 4 Pt 1), 1362\u20131380 (2010)","journal-title":"J Sex Med"},{"issue":"Jan 1","key":"4020_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.eururo.2004.08.017","volume":"47","author":"A Ponholzer","year":"2005","unstructured":"A. Ponholzer, C. Temml, K. Mock et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 47(Jan 1), 80\u201385 (2005).","journal-title":"Eur Urol"},{"issue":"Jan 1","key":"4020_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1743-6109.2008.01059.x","volume":"6","author":"G Corona","year":"2009","unstructured":"G. Corona, E. Mannucci, F. Lotti et al. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6(Jan 1), 285\u2013293 (2009)","journal-title":"J Sex Med"},{"issue":"Nov 11","key":"4020_CR12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s40618-023-02136-x","volume":"46","author":"DG Corona","year":"2023","unstructured":"D.G. Corona, W. Vena, A. Pizzocaro et al. Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study. J Endocrinol Invest 46(Nov 11), 2195\u20132211 (2023)","journal-title":"J Endocrinol Invest"},{"issue":"Jul 7","key":"4020_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/HJH.0000000000002382","volume":"38","author":"M Viigimaa","year":"2020","unstructured":"M. Viigimaa, C. Vlachopoulos, M. Doumas et al. Update of the position paper on arterial hypertension and erectile dysfunction. J Hypertens 38(Jul 7), 1220\u20131234 (2020)","journal-title":"J Hypertens"},{"issue":"Sep 3","key":"4020_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","volume":"80","author":"A Salonia","year":"2021","unstructured":"A. Salonia, C. Bettocchi, L. Boeri et al. European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol 80(Sep 3), 333\u2013357 (2021)","journal-title":"Eur Urol"},{"issue":"Jun 6","key":"4020_CR15","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/jsm.12525","volume":"11","author":"M Gacci","year":"2014","unstructured":"M. Gacci, V. Ficarra, A. Sebastianelli et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med 11(Jun 6), 1554\u20131566 (2014)","journal-title":"J Sex Med"},{"issue":"Jun 3","key":"4020_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF01541742","volume":"17","author":"RC Rosen","year":"1988","unstructured":"R.C. Rosen, J.B. Kostis, A.W. Jekelis, Beta-blocker effects on sexual function in normal males. Arch Sex Behav 17(Jun 3), 241\u2013255 (1988)","journal-title":"Arch Sex Behav"},{"issue":"Apr 2","key":"4020_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF01542095","volume":"23","author":"RC Rosen","year":"1994","unstructured":"R.C. Rosen, J.B. Kostis, A. Jekelis et al. Sexual sequelae of antihypertensive drugs: treatment effects on self-report and physiological measures in middle-aged male hypertensives. Arch Sex Behav 23(Apr 2), 135\u2013152 (1994)","journal-title":"Arch Sex Behav"},{"issue":"1","key":"4020_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1755-5922.2009.00123.x","volume":"28","author":"A Cordero","year":"2010","unstructured":"A. Cordero, V. Bertomeu-Mart\u00ednez, P. Maz\u00f3n et al. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther 28(1), 15\u201322 (2010)","journal-title":"Cardiovasc Ther"},{"issue":"Nov 21","key":"4020_CR19","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","volume":"24","author":"A Silvestri","year":"2003","unstructured":"A. Silvestri, P. Galetta, E. Cerquetani et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 24(Nov 21), 1928\u20131932 (2003)","journal-title":"Eur Heart J"},{"issue":"Apr 4","key":"4020_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1440-1681.2007.04551.x","volume":"34","author":"K Brixius","year":"2007","unstructured":"K. Brixius, M. Middeke, A. Lichtenthal et al. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 34(Apr 4), 327\u2013331 (2007)","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Apr 2","key":"4020_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5761\/atcs.oa.16-00242","volume":"23","author":"\u00d6 G\u00fcr","year":"2017","unstructured":"\u00d6. G\u00fcr, S. Gurkan, G. Yumun et al. The comparison of the effects of nebivolol and metoprolol on erectile dysfunction in the cases with coronary artery bypass surgery. Ann Thorac Cardiovasc Surg 23(Apr 2), 91\u201395 (2017)","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"Feb 2","key":"4020_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1743-6109.2007.00663.x","volume":"5","author":"G Corona","year":"2008","unstructured":"G. Corona, V. Ricca, E. Bandini et al. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 5(Feb 2), 458\u2013468 (2008)","journal-title":"J Sex Med"},{"issue":"May-Jun 3","key":"4020_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2164\/jandrol.05154","volume":"27","author":"G Corona","year":"2006","unstructured":"G. Corona, E. Mannucci, L. Petrone et al. Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl 27(May-Jun 3), 453\u2013458 (2006)","journal-title":"J Androl"},{"issue":"Oct-Dec 4","key":"4020_CR24","first-page":"569","volume":"14","author":"G Corona","year":"2015","unstructured":"G. Corona, S. Bianchini, A. Sforza et al. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones 14(Oct-Dec 4), 569\u2013578 (2015)","journal-title":"Hormones"},{"issue":"Apr 4","key":"4020_CR25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/jsm.12832","volume":"12","author":"E Maseroli","year":"2015","unstructured":"E. Maseroli, G. Corona, G. Rastrelli et al. Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med 12(Apr 4), 956\u2013965 (2015)","journal-title":"J Sex Med"},{"issue":"Oct 5","key":"4020_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2605.2009.00965.x","volume":"32","author":"G Corona","year":"2009","unstructured":"G. Corona, E. Mannucci, G. Forti et al. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl 32(Oct 5), 431\u2013441 (2009)","journal-title":"Int J Androl"},{"issue":"Jul 1","key":"4020_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bju.15313","volume":"128","author":"H Mostafaei","year":"2021","unstructured":"H. Mostafaei, K. Mori, S. Hajebrahimi et al. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU Int 128(Jul 1), 3\u201311 (2021)","journal-title":"BJU Int"},{"issue":"Oct 5","key":"4020_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.pcd.2022.09.004","volume":"16","author":"S Seidu","year":"2022","unstructured":"S. Seidu, A. Cebri\u00e1n, S.K. Kunutsor et al. Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: a systematic review and meta-analysis. Prim Care Diabetes 16(Oct 5), 601\u2013613 (2022)","journal-title":"Prim Care Diabetes"},{"issue":"Sep 490","key":"4020_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1192\/bjp.112.490.917","volume":"112","author":"S Crown","year":"1966","unstructured":"S. Crown, A.H. Crisp, A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 112(Sep 490), 917\u2013923 (1966)","journal-title":"Br J Psychiatry"},{"issue":"Sep 9","key":"4020_CR30","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1743-6109.2011.02342.x","volume":"8","author":"M Karavitakis","year":"2011","unstructured":"M. Karavitakis, C. Komninos, P.N. Theodorakis et al. Evaluation of sexual function in hypertensive men receiving treatment: a review of current guidelines recommendation. J Sex Med 8(Sep 9), 2405\u20132414 (2011)","journal-title":"J Sex Med"},{"issue":"Jun 6","key":"4020_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"G. Mancia, G. De Backer, A. Dominiczak et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(Jun 6), 1105\u20131187 (2007)","journal-title":"J Hypertens"},{"issue":"Jul 2","key":"4020_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0163-8343(82)90041-X","volume":"4","author":"HB Moss","year":"1982","unstructured":"H.B. Moss, W.R. Procci, Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature. Gen Hosp Psychiatry 4(Jul 2), 121\u2013129 (1982)","journal-title":"Gen Hosp Psychiatry"},{"issue":"Feb 1","key":"4020_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1445-5994.1974.tb03142.x","volume":"4","author":"MC Laver","year":"1974","unstructured":"M.C. Laver, Sexual behaviour patterns in male hypertensives. Aust N Z J Med 4(Feb 1), 29\u201331 (1974)","journal-title":"Aust N Z J Med"},{"issue":"May 5969","key":"4020_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/bmj.2.5969.501-a","volume":"2","author":"WD Alexander","year":"1975","unstructured":"W.D. Alexander, J.I. Evans, Letter: side effects of methyldopa. Br Med J 2(May 5969), 501 (1975)","journal-title":"Br Med J"},{"issue":"Apr 2","key":"4020_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.ijir.3900393","volume":"11","author":"B Srilatha","year":"1999","unstructured":"B. Srilatha, P.G. Adaikan, S. Arulkumaran et al. Sexual dysfunction related to antihypertensive agents: results from the animal model. Int J Impot Res 11(Apr 2), 107\u2013113 (1999)","journal-title":"Int J Impot Res"},{"issue":"Mar-Apr 2","key":"4020_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.ijir.3901516","volume":"19","author":"R Shiri","year":"2007","unstructured":"R. Shiri, J. Koskim\u00e4ki, J. H\u00e4kkinen et al. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res 19(Mar-Apr 2), 208\u2013212 (2007)","journal-title":"Int J Impot Res"},{"issue":"Mar 2","key":"4020_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1745-7262.2006.00076.x","volume":"8","author":"M Doumas","year":"2006","unstructured":"M. Doumas, A. Tsakiris, S. Douma et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 8(Mar 2), 177\u2013182 (2006)","journal-title":"Asian J Androl"},{"issue":"Mar 3","key":"4020_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","volume":"65","author":"M Baumh\u00e4kel","year":"2011","unstructured":"M. Baumh\u00e4kel, N. Schlimmer, M. Kratz et al. Cardiovascular risk, drugs and erectile function-a systematic analysis. Int J Clin Pract 65(Mar 3), 289\u2013298 (2011)","journal-title":"Int J Clin Pract"},{"issue":"Jun 6","key":"4020_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1592\/phco.21.7.676.34571","volume":"21","author":"CA Derby","year":"2001","unstructured":"C.A. Derby, M.M. Barbour, A.L. Hume et al. Drug therapy and prevalence of erectile dysfunction in the Massachusetts male aging study cohort. Pharmacotherapy 21(Jun 6), 676\u2013683 (2001)","journal-title":"Pharmacotherapy"},{"key":"4020_CR40","first-page":"190","volume":"101","author":"HG Langford","year":"1990","unstructured":"H.G. Langford, R.W. Rockhold, S. Wassertheil-Smoller et al. Effect of weight loss on thiazide produced erectile problems in men. Trans Am Clin Climatol Assoc 101, 190\u2013194 (1990)","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"May 5","key":"4020_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/014107688908200509","volume":"82","author":"JE Marley","year":"1989","unstructured":"J.E. Marley, Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice. J R Soc Med 82(May 5), 272\u2013275 (1989)","journal-title":"J R Soc Med"},{"issue":"Feb 1","key":"4020_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10557-006-6312-4","volume":"20","author":"PA Poole-Wilson","year":"2006","unstructured":"P.A. Poole-Wilson, B.A. Kirwan, Z. Vok\u00f3 et al. Safety of nifedipine GITS in stable angina: the ACTION trial. Cardiovasc Drugs Ther 20(Feb 1), 45\u201354 (2006)","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Nov 5","key":"4020_CR43","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0022-5347(17)43582-8","volume":"138","author":"M Fovaeus","year":"1987","unstructured":"M. Fovaeus, K.E. Andersson, H. Hedlund, Effects of some calcium channel blockers on isolated human penile erectile tissues. J Urol 138(Nov 5), 1267\u20131272 (1987)","journal-title":"J Urol"},{"issue":"Jul 7","key":"4020_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1291\/hypres.29.523","volume":"29","author":"M Ushiyama","year":"2006","unstructured":"M. Ushiyama, T. Kuramochi, S. Katayama, Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats. Hypertens Res 29(Jul 7), 523\u2013532 (2006)","journal-title":"Hypertens Res"},{"issue":"Feb 2","key":"4020_CR45","doi-asserted-by":"publisher","first-page":"e2036337","DOI":"10.1001\/jamanetworkopen.2020.36337","volume":"4","author":"I Mykoniatis","year":"2021","unstructured":"I. Mykoniatis, N. Pyrgidis, I. Sokolakis et al. Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis. JAMA Netw Open 4(Feb 2), e2036337 (2021)","journal-title":"JAMA Netw Open"},{"issue":"May 5","key":"4020_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","volume":"61","author":"M Gacci","year":"2012","unstructured":"M. Gacci, G. Corona, M. Salvi et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61(May 5), 994\u20131003 (2012)","journal-title":"Eur Urol"},{"issue":"Mar 2","key":"4020_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1743-6109.2005.20230.x","volume":"2","author":"TG Speel","year":"2005","unstructured":"T.G. Speel, L.A. Kiemeney, T. Thien et al. Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study. J Sex Med 2(Mar 2), 207\u2013212 (2005)","journal-title":"J Sex Med"},{"issue":"May 5","key":"4020_CR48","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0022-5347(01)64901-2","volume":"157","author":"I Kifor","year":"1997","unstructured":"I. Kifor, G.H. Williams, M.A. Vickers et al. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 157(May 5), 1920\u20131925 (1997)","journal-title":"J Urol"},{"issue":"Jun 6","key":"4020_CR49","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74(Jun 6), 1141\u20131148 (1994)","journal-title":"Circ Res"},{"issue":"Nov-Dec 6","key":"4020_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319892735","volume":"13","author":"SB Ismail","year":"2019","unstructured":"S.B. Ismail, N.M. Noor, N.H.N. Hussain et al. Angiotensin receptor blockers for erectile dysfunction in hypertensive men: a brief meta-analysis of randomized control trials. Am J Mens Health 13(Nov-Dec 6), 1557988319892735 (2019)","journal-title":"Am J Mens Health"},{"issue":"Jul 669","key":"4020_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/pgmj.57.669.425","volume":"57","author":"RG Taylor","year":"1981","unstructured":"R.G. Taylor, A.J. Crisp, B.I. Hoffbrand et al. Plasma sex hormone concentrations in men with hypertension treated with methyldopa and\/or propranolol. Postgrad Med J 57(Jul 669), 425\u2013426 (1981)","journal-title":"Postgrad Med J"},{"issue":"Mar 3","key":"4020_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0895-7061(98)00225-8","volume":"12","author":"J Jensen","year":"1999","unstructured":"J. Jensen, A. Lendorf, H. Stimpel et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 12(Mar 3), 271\u2013275 (1999)","journal-title":"Am J Hypertens"},{"issue":"Oct 4","key":"4020_CR53","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S0022-5347(05)67138-8","volume":"164","author":"M Burchardt","year":"2000","unstructured":"M. Burchardt, T. Burchardt, L. Baer et al. Hypertension is associated with severe erectile dysfunction. J Urol 164(Oct 4), 1188\u20131191 (2000)","journal-title":"J Urol"},{"issue":"Oct 5","key":"4020_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/sj.ijir.3901041","volume":"15","author":"WA Blumentals","year":"2003","unstructured":"W.A. Blumentals, R.R. Brown, A. Gomez-Caminero, Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Int J Impot Res 15(Oct 5), 314\u2013317 (2003)","journal-title":"Int J Impot Res"},{"issue":"Dec 4","key":"4020_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13685530312331309752","volume":"6","author":"WA Blumentals","year":"2003","unstructured":"W.A. Blumentals, A. Gomez-Caminero, S. Joo et al. Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 6(Dec 4), 217\u2013221 (2003)","journal-title":"Aging Male"},{"issue":"Apr 4","key":"4020_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1464-5491.2003.00911.x","volume":"20","author":"PK Moulik","year":"2003","unstructured":"P.K. Moulik, K.J. Hardy, Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 20(Apr 4), 290\u2013293 (2003)","journal-title":"Diabet Med"},{"issue":"Jan 1","key":"4020_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/clc.4960260106","volume":"26","author":"A Roth","year":"2003","unstructured":"A. Roth, O. Kalter-Leibovici, Y. Kerbis et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol 26(Jan 1), 25\u201330 (2003)","journal-title":"Clin Cardiol"},{"issue":"Nov 22","key":"4020_CR58","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehl142","volume":"27","author":"P Montorsi","year":"2006","unstructured":"P. Montorsi, P.M. Ravagnani, S. Galli et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 27(Nov 22), 2632\u20132639 (2006)","journal-title":"Eur Heart J"},{"issue":"Jul 1","key":"4020_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2007.03.024","volume":"154","author":"M B\u00f6hm","year":"2007","unstructured":"M. B\u00f6hm, M. Baumh\u00e4kel, J.L. Probstfield et al. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ongoing telmisartan alone and in combination with Ramipril Global endpoint trial\/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease (ONTARGET\/TRANSCEND). Am Heart J 154(Jul 1), 94\u2013101 (2007)","journal-title":"Am Heart J"},{"issue":"Feb 1","key":"4020_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1358863X06076043","volume":"12","author":"J Falkensammer","year":"2007","unstructured":"J. Falkensammer, A.G. Hakaim, C.E. Falkensammer et al. Prevalence of erectile dysfunction in vascular surgery patients. Vasc Med 12(Feb 1), 17\u201322 (2007)","journal-title":"Vasc Med"},{"issue":"Sep 9","key":"4020_CR61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1157\/13125512","volume":"61","author":"JM Maroto-Montero","year":"2008","unstructured":"J.M. Maroto-Montero, M.T. Portuondo-Maseda, M. Lozano-Su\u00e1rez et al. Erectile dysfunction in patients in a cardiac rehabilitation program. Rev Esp Cardiol 61(Sep 9), 917\u2013922 (2008)","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"4020_CR62","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/10641963.2015.1060994","volume":"38","author":"N Artom","year":"2016","unstructured":"N. Artom, G. Pinna, N.R. Musso et al. Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects. Clin Exp Hypertens 38(2), 143\u2013149 (2016)","journal-title":"Clin Exp Hypertens"},{"issue":"Apr 1","key":"4020_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4244-x","volume":"12","author":"B Nisahan","year":"2019","unstructured":"B. Nisahan, T. Kumanan, N. Rajeshkannan et al. Erectile dysfunction and associated factors among men with diabetes mellitus from a tertiary diabetic center in Northern Sri Lanka. BMC Res Notes 12(Apr 1), 210 (2019)","journal-title":"BMC Res Notes"},{"issue":"Jun 2","key":"4020_CR64","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4314\/ahs.v22i2.48","volume":"22","author":"MC Correia","year":"2022","unstructured":"M.C. Correia, E.N. Ogola, J.K. Kayima et al. Erectile dysfunction in hypertensive males in Kenya: a tertiary referral hospital experience. Afr Health Sci 22(Jun 2), 420\u2013427 (2022)","journal-title":"Afr Health Sci"},{"key":"4020_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1157467","volume":"10","author":"C Zhao","year":"2023","unstructured":"C. Zhao, J.L. Feng, S. Deng et al. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study. Front Cardiovasc Med 10, 1157467 (2023)","journal-title":"Front Cardiovasc Med"},{"issue":"Jul 2","key":"4020_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1056\/NEJM197607082950203","volume":"295","author":"JW Hollifield","year":"1976","unstructured":"J.W. Hollifield, K. Sherman, R.V. Zwagg et al. Proposed mechanisms of propranolol\u2019s antihypertensive effect in essential hypertension. N Engl J Med 295(Jul 2), 68\u201373 (1976)","journal-title":"N Engl J Med"},{"issue":"Dec","key":"4020_CR67","first-page":"341s","volume":"4","author":"GE Bauer","year":"1978","unstructured":"G.E. Bauer, J. Baker, S.N. Hunyor et al. Side-effects of antihypertensive treatment: a placebo-controlled study. Clin Sci Mol Med Suppl 4(Dec), 341s\u2013344s (1978)","journal-title":"Clin Sci Mol Med Suppl"},{"issue":"Apr 2","key":"4020_CR68","first-page":"125","volume":"3","author":"AE Fletcher","year":"1989","unstructured":"A.E. Fletcher, P.C. Chester, C.M. Hawkins et al. The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens 3(Apr 2), 125\u2013130 (1989)","journal-title":"J Hum Hypertens"},{"issue":"Sep 8246","key":"4020_CR69","first-page":"539","volume":"2","author":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension","year":"1981","unstructured":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension, Report of medical research council working party on mild to moderate hypertension. Lancet 2(Sep 8246), 539\u2013543 (1981)","journal-title":"Lancet"},{"issue":"Jun 6","key":"4020_CR70","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0735-1097(85)80360-0","volume":"5","author":"G Olsson","year":"1985","unstructured":"G. Olsson, N. Rehnqvist, A. Sj\u00f6gren et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. J Am Coll Cardiol 5(Jun 6), 1428\u20131437 (1985)","journal-title":"J Am Coll Cardiol"},{"issue":"Apr 8","key":"4020_CR71","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","volume":"114","author":"S Wassertheil-Smoller","year":"1991","unstructured":"S. Wassertheil-Smoller, M.D. Blaufox, A. Oberman et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 114(Apr 8), 613\u2013620 (1991)","journal-title":"Ann Intern Med"},{"issue":"4","key":"4020_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00926239208412857","volume":"18","author":"CP Broekman","year":"1992","unstructured":"C.P. Broekman, S.M. Haensel, L.L. Van de Ven et al. Bisoprolol and hypertension: effects on sexual functioning in men. J Sex Marital Ther 18(4), 325\u2013331 (1992). Winter","journal-title":"J Sex Marital Ther"},{"issue":"Apr 2","key":"4020_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01542360","volume":"22","author":"DL Morrissette","year":"1993","unstructured":"D.L. Morrissette, M.H. Skinner, B.B. Hoffman et al. Effects of antihypertensive drugs atenolol and nifedipine on sexual function in older men: a placebo-controlled, crossover study. Arch Sex Behav 22(Apr 2), 99\u2013109 (1993)","journal-title":"Arch Sex Behav"},{"issue":"Oct 10","key":"4020_CR74","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S0895-7061(98)00139-3","volume":"11","author":"R Fogari","year":"1998","unstructured":"R. Fogari, A. Zoppi, L. Corradi et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11(Oct 10), 1244\u20131247 (1998)","journal-title":"Am J Hypertens"},{"issue":"Jan 1","key":"4020_CR75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0895-7061(00)01214-0","volume":"14","author":"R Fogari","year":"2001","unstructured":"R. Fogari, A. Zoppi, L. Poletti et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 14(Jan 1), 27\u201331 (2001)","journal-title":"Am J Hypertens"},{"issue":"Dec 6","key":"4020_CR76","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.ijir.3900787","volume":"13","author":"D Franzen","year":"2001","unstructured":"D. Franzen, A. Metha, N. Seifert et al. Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int J Impot Res 13(Dec 6), 348\u2013351 (2001)","journal-title":"Int J Impot Res"},{"issue":"Jun 3","key":"4020_CR77","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00228-002-0456-3","volume":"58","author":"R Fogari","year":"2002","unstructured":"R. Fogari, P. Preti, G. Derosa et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 58(Jun 3), 177\u2013180 (2002)","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"4020_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2165\/00044011-200525060-00006","volume":"25","author":"B Boydak","year":"2005","unstructured":"B. Boydak, S. Nalbantgil, F. Fici et al. A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Investig 25(6), 409\u2013416 (2005)","journal-title":"Clin Drug Investig"},{"issue":"May 22","key":"4020_CR79","first-page":"1659","volume":"344","author":"EJ Eichhorn","year":"2001","unstructured":"E.J. Eichhorn, M.J. Domanski, H. Krause-Steinrauf et al. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344(May 22), 1659\u20131667 (2001)","journal-title":"N Engl J Med"},{"issue":"Jan 1","key":"4020_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0149-2918(01)80034-5","volume":"23","author":"F Freytag","year":"2001","unstructured":"F. Freytag, A. Schelling, T. Meinicke et al. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study. Clin Ther 23(Jan 1), 108\u2013123 (2001)","journal-title":"Clin Ther"},{"issue":"Aug 8","key":"4020_CR81","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjhyper.2005.03.733","volume":"18","author":"LM Van Bortel","year":"2005","unstructured":"L.M. Van Bortel, C.J. Bulpitt, F. Fici, Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens 18(Aug 8), 1060\u20131066 (2005)","journal-title":"Am J Hypertens"},{"issue":"Feb 2","key":"4020_CR82","first-page":"131","volume":"16","author":"Aldemir","year":"2016","unstructured":"Aldemir, M. Kele\u015f, \u0130, M. Karalar et al. Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft. Anatol J Cardiol 16(Feb 2), 131\u2013136 (2016)","journal-title":"Anatol J Cardiol"},{"issue":"Mar 10","key":"4020_CR83","first-page":"e56","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"E.J. Benjamin, P. Muntner, A. Alonso et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139(Mar 10), e56\u2013e528 (2019)","journal-title":"Circulation"},{"issue":"Sep 9","key":"4020_CR84","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"C.K. Chow, K.K. Teo, S. Rangarajan et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(Sep 9), 959\u2013968 (2013)","journal-title":"JAMA"},{"issue":"Jun 6","key":"4020_CR85","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.amepre.2010.02.016","volume":"38","author":"TA Farley","year":"2010","unstructured":"T.A. Farley, M.A. Dalal, F. Mostashari et al. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 38(Jun 6), 600\u2013609 (2010)","journal-title":"Am J Prev Med"},{"issue":"Feb","key":"4020_CR86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/PPA.S3796","volume":"2","author":"CI Voils","year":"2008","unstructured":"C.I. Voils, M. Sandelowski, P. Dahm et al. Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency. Patient Prefer Adherence 2(Feb), 201\u2013206 (2008)","journal-title":"Patient Prefer Adherence"},{"issue":"Nov","key":"4020_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.009","volume":"81","author":"A Manolis","year":"2020","unstructured":"A. Manolis, M. Doumas, C. Ferri et al. Erectile dysfunction and adherence to antihypertensive therapy: focus on \u03b2-blockers. Eur J Intern Med 81(Nov), 1\u20136 (2020)","journal-title":"Eur J Intern Med"},{"issue":"Jun 6","key":"4020_CR88","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"T. Unger, C. Borghi, F. Charchar et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension 75(Jun 6), 1334\u20131357 (2020)","journal-title":"Hypertension"},{"issue":"Jun 6","key":"4020_CR89","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"P.K. Whelton, R.M. Carey, W.S. Aronow et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(Jun 6), 1269\u20131324 (2018)","journal-title":"Hypertension"},{"key":"4020_CR90","unstructured":"Guideline for the Pharmacological Treatment of Hypertension in Adults. Geneve. World Health Organization; 2021. 2021. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/344424\/9789240033986-eng.pdf"},{"issue":"Jun 7200","key":"4020_CR91","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"N. Freemantle, J. Cleland, P. Young et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. Bmj 318(Jun 7200), 1730\u20131737 (1999)","journal-title":"Bmj"},{"issue":"Feb 5","key":"4020_CR92","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","volume":"101","author":"MR Bristow","year":"2000","unstructured":"M.R. Bristow, beta-adrenergic receptor blockade in chronic heart failure. Circulation 101(Feb 5), 558\u2013569 (2000)","journal-title":"Circulation"},{"issue":"Jan 1","key":"4020_CR93","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jsm.12342","volume":"11","author":"G Rastrelli","year":"2014","unstructured":"G. Rastrelli, G. Corona, F. Lotti et al. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. J Sex Med 11(Jan 1), 173\u2013186 (2014)","journal-title":"J Sex Med"},{"issue":"1","key":"4020_CR94","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1573402114666180918102735","volume":"15","author":"GT do Vale","year":"2019","unstructured":"G.T. do Vale, C.S. Ceron, N.A. Gonzaga et al. Three generations of \u03b2-blockers: history, class differences and clinical applicability. Curr Hypertens Rev 15(1), 22\u201331 (2019)","journal-title":"Curr Hypertens Rev"},{"issue":"Nov 8","key":"4020_CR95","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2217\/fca-2021-0048","volume":"17","author":"C Ferri","year":"2021","unstructured":"C. Ferri, The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines. Future Cardiol 17(Nov 8), 1421\u20131433 (2021)","journal-title":"Future Cardiol"},{"issue":"Dec 12","key":"4020_CR96","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","volume":"45","author":"AM Isidori","year":"2022","unstructured":"A.M. Isidori, A. Aversa, A. Calogero et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(Dec 12), 2385\u20132403 (2022)","journal-title":"J Endocrinol Invest"},{"issue":"Jun 2","key":"4020_CR97","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1517\/14728214.2012.683411","volume":"17","author":"G Corona","year":"2012","unstructured":"G. Corona, G. Rastrelli, L. Vignozzi et al. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs 17(Jun 2), 239\u2013259 (2012)","journal-title":"Expert Opin Emerg Drugs"},{"issue":"Jul 3","key":"4020_CR98","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jama.288.3.351","volume":"288","author":"DT Ko","year":"2002","unstructured":"D.T. Ko, P.R. Hebert, C.S. Coffey et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288(Jul 3), 351\u2013357 (2002)","journal-title":"JAMA"},{"issue":"Jan 1","key":"4020_CR99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/FJC.0b013e3182073e27","volume":"59","author":"Y Gao","year":"2012","unstructured":"Y. Gao, P.M. Vanhoutte, Nebivolol: an endothelium-friendly selective \u03b21-adrenoceptor blocker. J Cardiovasc Pharmacol 59(Jan 1), 16\u201321 (2012)","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"4020_CR100","first-page":"28","volume":"15","author":"IMF Wikananda","year":"2024","unstructured":"I.M.F. Wikananda, I. Nurcahya, P. Wijaya et al. Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis. Caspian J Intern Med 15(1), 28\u201337 (2024)","journal-title":"Caspian J Intern Med"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04020-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:01:50Z","timestamp":1737014510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04020-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}